Tau Beats Amyloid in Predicting Brain Atrophy in Alzheimer Disease: Implications for Prognosis and Clinical Trials.

Malpetti, Maura; Joie, Renaud La; Rabinovici, Gil D

View / Open Files

Accepted version (PDF, 344Kb)

Authors

Malpetti, Maura

Joie, Renaud La

Rabinovici, Gil D

Publication Date

2022-06

Journal Title

J Nucl Med

ISSN

0161-5505

Publisher

Society of Nuclear Medicine

Volume

Issue

Pages

830-832

Type

Article

This Version

Physical Medium

Metadata

Show full item record

Citation

Malpetti, M., Joie, R. L., & Rabinovici, G. D. (2022). Tau Beats Amyloid in Predicting Brain Atrophy in Alzheimer Disease: Implications for Prognosis and Clinical Trials.. J Nucl Med, 63 (6), 830-832. https://doi.org/10.2967/jnumed.121.263694

Keywords

Alzheimer Disease, Amyloid, Amyloidogenic Proteins, Amyloidosis, Atrophy, Brain, Clinical Trials as Topic, Humans, Prognosis

Sponsorship

Medical Research Council (MR/M008983/1)

Medical Research Council (MC_U105597119)

MRC (via University of Oxford) (MR/T033371/1)

Medical Research Council (MC_UU_00005/12)

Medical Research Council (MR/L023784/2)

Identifiers

External DOI: https://doi.org/10.2967/jnumed.121.263694

This record's URL: https://www.repository.cam.ac.uk/handle/1810/341563

Rights

Licence URL: http://www.rioxx.net/licenses/all-rights-reserved

Statistics

Total file downloads (since January 2020). For more information on metrics see the IRUS guide.